EPR - the future of bio/pharmaceutical analysis online summit 2025 logo

The Future of

Bio/Pharmaceutical Analysis

Ben Shapiro

Ben Shapiro

Director – Digital Product Development and Marketing

U.S. Pharmacopeia

Ben joined USP in 2020 and is responsible for digital product development aimed at transforming the way scientists receive and consume chemical reference information. Ben developed Quantitative Nuclear Magnetic Resonance (qNMR) software for NMR analysis applications in pharmaceutical R&D, quality control, process chemistry, and analytical chemistry, and is working to develop new categories of integrated digital standards to help scientists ensure the quality of medicines they test. Ben also leads development for the Medicine Supply Map, a supply chain intelligence product that provides visibility of the generic pharmaceutical supply chain and drug shortage risks.

Prior to joining USP, Ben was a Senior Product Manager at Mettler-Toledo Autochem, responsible for particle characterization process analytical technology (PAT), where he developed and launched the EasyViewer and iC Vision product lines. Ben is experienced in nurturing technologies, developing new products, and helping life science organizations navigate disruptive innovation, having more than a decade of experience as a product manager and product leader serving the pharmaceutical industry with innovative technologies. Ben holds a master of science degree in materials science and a bachelor of science degree in chemical engineering from the University of Maryland in College Park, as well as an MBA from The Johns Hopkins University Carey Business School.